Skip to main content
Erschienen in: Journal of Neurology 11/2023

Open Access 18.07.2023 | Original Communication

Longitudinal changes in qualitative aspects of semantic fluency in presymptomatic and prodromal genetic frontotemporal dementia

verfasst von: Lize C. Jiskoot, Esther van den Berg, Sascha A. A. M. Laenen, Jackie M. Poos, Lucia A. A. Giannini, Djaina D. Satoer, Judy van Hemmen, Yolande A. L. Pijnenburg, Jet M. J. Vonk, Harro Seelaar

Erschienen in: Journal of Neurology | Ausgabe 11/2023

Abstract

Background

The semantic fluency test is one of the most widely used neuropsychological tests in dementia diagnosis. Research utilizing the qualitative, psycholinguistic information embedded in its output is currently underexplored in presymptomatic and prodromal genetic FTD.

Methods

Presymptomatic MAPT (n = 20) and GRN (n = 43) mutation carriers, and controls (n = 55) underwent up to 6 years of neuropsychological assessment, including the semantic fluency test. Ten mutation carriers became symptomatic (phenoconverters). Total score and five qualitative fluency measures (lexical frequency, age of acquisition, number of clusters, cluster size, number of switches) were calculated. We used multilevel linear regression modeling to investigate longitudinal decline. We assessed the co-correlation of the qualitative measures at each time point with principal component analysis. We explored associations with cognitive decline and grey matter atrophy using partial correlations, and investigated classification abilities using binary logistic regression.

Results

The interrater reliability of the qualitative measures was good (ICC = 0.75–0.90). There was strong co-correlation between lexical frequency and age of acquisition, and between clustering and switching. At least 4 years pre-phenoconversion, GRN phenoconverters had fewer but larger clusters (p < 0.001), and fewer switches (p = 0.004), correlating with lower executive function (r = 0.87–0.98). Fewer switches was predictive of phenoconversion, correctly classifying 90.3%. Starting at least 4 years pre-phenoconversion, MAPT phenoconverters demonstrated an increase in lexical frequency (p = 0.009) and a decline in age of acquisition (p = 0.034), correlating with lower semantic processing (r = 0.90). Smaller cluster size was predictive of phenoconversion, correctly classifying 89.3%. Increase in lexical frequency and decline in age of acquisition were associated with grey matter volume loss of predominantly temporal areas, while decline in the number of clusters, cluster size, and switches correlated with grey matter volume loss of predominantly frontal areas.

Conclusions

Qualitative aspects of semantic fluency could give insight into the underlying mechanisms as to why the “traditional” total score declines in the different FTD mutations. However, the qualitative measures currently demonstrate more fluctuation than the total score, the measure that seems to most reliably deteriorate with time. Replication in a larger sample of FTD phenoconverters is warranted to identify if qualitative measures could be sensitive cognitive biomarkers to identify and track mutation carriers converting to the symptomatic stage of FTD.

Introduction

Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous type of early-onset dementia, typically characterized by atrophy of the frontal and/or temporal lobes [1]. The clinical profile of FTD shows behavioural and language disturbances, with cognitive deficits in executive function and relative sparing of memory and visuospatial abilities [2]. Up to 40% of FTD cases have an autosomal dominant pattern of inheritance. Mutations in the progranulin (GRN), microtubule-associated protein tau (MAPT) and chromosome 9 open reading frame 72 (C9orf72) genes are the most common causes [3]. Early diagnosis—albeit difficult due to the heterogeneous symptoms and overlap with other forms of dementia and psychiatric disorders—is essential for proper patient management and planning, non-pharmacological treatment, and patient stratification in upcoming disease-modifying clinical trials [4].
Research in the genetic FTD field has been increasingly moving towards the presymptomatic and early prodromal stages, as the critical time-window for treatment most likely lies prior to overt symptom onset. With promising avenues opening for clinical trials, identifying robust biomarkers is of utmost importance [5]. Previous neuropsychological studies showed that subtle cognitive deficits and decline are present in the presymptomatic stage, and gene-specific cognitive profiles can be detected [68]. These findings suggest that neuropsychological assessment in the presymptomatic and early prodromal stages can provide sensitive cognitive markers for FTD.
The semantic fluency test is one of the most widely used tests in neuropsychological assessments. In this brief, easy-to-apply test, people have to generate items from a particular semantic category (e.g., animals, foods) in 1 min [9]. The semantic fluency test presents high sensitivity and specificity for dementia diagnosis [9], with impaired performance found in both symptomatic [10] and presymptomatic FTD [7, 8]. Although the total number of items generated is commonly used to quantify test performance, qualitative, psycholinguistic information embedded in the output can also be investigated, including clusters (number of multiword strings1), switches (number of transitions between clusters), age of acquisition (AoA; the age at which a word is learned), and lexical frequency (LF; how often a word occurs in daily language) [12, 13]. Previous research demonstrated the prognostic value of qualitative fluency measures in cognitively healthy subjects at-risk for and in conversion from prodromal to overt Alzheimer’s Dementia (AD) [14, 15]. This approach has been underexplored in presymptomatic and/or prodromal genetic FTD, while this psycholinguistic information may be able to detect the subtle development of FTD’s characteristic language symptoms at an early stage.
The aim of this study was therefore to investigate longitudinal changes in five qualitative aspects of semantic fluency (i.e., number of clusters and switches, cluster size, AoA, and LF) in mutation carriers that developed FTD (phenoconverters), presymptomatic mutation carriers, and non-carriers from autosomal dominant GRN- and MAPT-FTD families. We were specifically interested in the inflection point (i.e., when in the disease trajectory) at which the qualitative measures start to deviate from normal. Additionally, we explored the co-correlation between the qualitative measures, and their associations with cognitive decline and grey matter (GM) volume loss, and the prognostic value of decline in qualitative measures in predicting symptomatic onset.

Methods

Participants

We included longitudinal data of 118 participants from the FTD Risk Cohort of the Erasmus MC University Medical Center (Rotterdam, the Netherlands). This is an ongoing study in which first-degree family members of FTD patients due to a pathogenic mutation are followed on a 1- or 2-year basis [16]. Participants were recruited between February 2010 and October 2019. DNA genotyping at study entry assigned participants to the mutation carrier (n = 63; MAPT n = 20, GRN n = 43) or non-carrier group (controls; n = 55). Upon study entry, all mutation carriers were presymptomatic according to clinical diagnostic criteria for FTD [2, 17, 18], and had global CDR®-plus-NACC-FTLD [19] scores of 0. Ten mutation carriers (MAPT n = 6, GRN n = 4) developed symptoms during follow-up (phenoconverters). Diagnoses were made in multidisciplinary consensus meetings, using information from the standardized clinical assessment (see below). Phenoconverters met the following criteria: [i] progressive deterioration of behaviour, language and/or motor functioning; [ii] functional decline, evidenced by multiple study visits with global CDR®-plus-NACC-FTLD [19] ≥ 0.5 without reversing back to 0; and [iii] cognitive decline, evidenced by ≥ 1.5 SD below age-, sex- and education-specific means in ≥ 1 domain on neuropsychological assessment. Eight phenoconverters had clinical features of bvFTD (MAPT n = 6, GRN n = 2), and two had non-fluent variant PPA (GRN n = 2). The presymptomatic mutation carriers that did not develop FTD symptoms are referred to as non-converters (n = 53).

Clinical assessment

Every 1–2 years, all participants underwent a standardized clinical assessment, consisting of a structured interview with the participant and a knowledgeable informant (incorporating the CDR®-plus-NACC-FTLD [19]), medical history taking, neurological examination, neuropsychological assessment, and brain MRI. The neuropsychological assessment consisted of cognitive screening tests (Mini-Mental State Examination, MMSE, and Frontal Assessment Battery, FAB), and tests within the major cognitive domains. Neuropsychiatric symptoms were assessed with the Beck’s Depression Inventory (BDI) and the brief questionnaire form of the Neuropsychiatric Inventory (NPI-Q) (see [7, 8] for full test battery).

Qualitative fluency measures

The semantic fluency task was part of the neuropsychological assessment at each study visit. In this task, participants were asked to verbally generate as many different animals as possible in 60 s [20]. The total score is the number of animals produced minus errors. Additionally, we calculated five qualitative fluency measures from the output: LF, AoA, number of clusters, cluster size and number of switches (Box 1, Appendix 1 for scoring guidelines).

Box 1. The 5 qualitative measures generated from the semantic fluency output

  • Lexical Frequency (LF)—a measure of how often a particular word occurs in daily language. Higher LF indicates worse performance (i.e. more use of high frequency words). Each generated word was paired with its log-transformed LF value from the SUBTLEX-NL database, so that it reflects the natural logarithmic value of how often a word occurs per one million Dutch words. The SUBTLEX-NL database was based on 44 million words from Dutch film and TV subtitles [21]. For this study, the mean LF per participant per study visit was used for subsequent analysis.
  • Age of Acquisition (AoA)—reflects the age at which a word is typically learned based on ratings of adults. Lower AoA indicates worse performance (i.e. loss of later acquired words). Each generated word was paired with its AoA from a database containing 30,000 Dutch words [22]. For this study, the mean AoA per participant per study visit was used for subsequent analysis.
  • Number of clusters—constitutes the number of related multiword strings (e.g., pets, birds), with a minimum of at least two successive words within a semantic subcategory [13]. A lower number of clusters indicates worse performance.
  • Cluster size—is the sum of all clustered words. The mean cluster size per participant per study visit was used for subsequent analysis (i.e. total cluster size divided by the number of clusters). Lower cluster size indicates worse performance.
  • Number of switches—defined as the number of transitions between different clusters, between clustered and non-clustered words (i.e. transitions from one associative strategy to none at all), or between non-clustered and other non-clustered words [13]. A lower number of switches indicates worse performance.

Study design

Phenoconverters, non-converters and controls were compared at five time points: baseline, and follow-up after 2, 4, 5 and 6 years, for the purpose of this study restructured as (Fig. 1):
1.
Four years before phenoconversion—data were available for six phenoconverters. The other four developed symptoms between baseline and the first follow-up visit, therefore no data 4 years prior to phenoconversion were available. The data were compared to the baseline data of non-converters and controls.
 
2.
Two years before phenoconversion—data were available for all ten phenoconverters. The data were compared to the 2-year follow-up data of non-converters and controls.
 
3.
Phenoconversion—data were available for all ten phenoconverters. The data were compared to the 4-year follow-up data of non-converters and controls.
 
4.
One year after phenoconversion—data were available for four phenoconverters. The other six were clinically too impaired to undergo neuropsychological testing or passed away (n = 4), or converted recently, therefore no data 1 year after phenoconversion were available yet (n = 2). The data were compared to the 5-year follow-up data of non-converters and controls.
 
5.
Two years after phenoconversion—data were available for four phenoconverters. The other six were clinically too impaired to undergo neuropsychological testing or passed away (n = 5), or converted recently therefore no data 1 year after phenoconversion were available yet (n = 1). The data were compared to the 6-year follow-up data of non-converters and controls.
 

MRI acquisition and (pre)processing

On each study visit, we performed volumetric T1-weighted MRI scanning on a Philips 3 T Achieva MRI scanner (Philips Medical Systems, Best, the Netherlands) using either an 8- or 32-channel SENSE head coil and the following scan parameters: inversion/repetition time = 933/2200 ms, flip angle = 8°, voxel size = 1.1 × 1.1 × 1.1 mm, matrix size = 256 × 256 × 208, total scan time = 4.43 min. All scans underwent visual quality control. The DICOM images were subsequently corrected for gradient nonlinearity distortions and converted to NifTI format. They were then pre-processed in the Voxel-Based Morphometry (VBM) pipeline in Statistical Parametric Mapping 12 (SPM12; Functional Imaging Laboratory, University College London, London, UK; www.​fil.​ion.​ucl.​ac.​uk/​spm) implemented in Matlab R2018a (Mathworks, USA). First, the T1-weighted images were normalized to a template space and segmented into GM, white matter (WM) and cerebrospinal fluid (CSF), after which they were rigidly aligned. We calculated total intracranial volume (TIV) by adding GM, WM and CSF. Second, the segmentations were spatially normalized to a DARTEL template by applying the flow fields of all the individual scans. Images were smoothed using a 6 mm full width at half maximum (FWHM) isotropic Gaussian kernel. After every preprocessing step, images were visually inspected.

Statistical analysis

We performed statistical analyses using SPSS Statistics 25.0 (IBM Corp., Armonk, NY). Alpha was set at 0.05 across all comparisons (two-tailed). We compared continuous demographic data between groups using one-way ANOVAs for normally distributed data (with Bonferroni post-hoc tests), or Kruskal–Wallis tests for non-normally distributed data (with Mann–Whitney U post-hoc tests). We analysed between-group differences in sex and gene with Pearson Χ2 tests. Interrater reliability was explored using intraclass correlation analysis. We assessed the co-correlation of the five qualitative measures at each time point by means of principal component analysis using Varimax rotation. Only factors accounting for 3% or more of variance and Eigenvalues > 1 were retained. Factor loadings were only considered meaningful when r > 0.450, and any item that did not load sufficiently onto a factor was removed [23]. For ease of interpretation, we first converted raw fluency and relevant neuropsychological measures (Boston Naming Test (BNT), Semantic Association Test (SAT), Trailmaking test B (TMT-B), Stroop colour-word test card III) into z-scores by subtracting the mean of controls from each individual’s raw score at that time point, divided by the SDs of controls at that time point. We then used multilevel linear regression modeling to investigate longitudinal decline in total and qualitative fluency measures. We performed two separate analyses to assess longitudinal change in qualitative fluency measures per [i] clinical status (phenoconverters, non-converters, controls) and [ii] gene (MAPT, GRN). We entered [i] or [ii], time, and first-order interactions, with age, sex, education and total number of words generated as covariates. Assumptions were checked (non-linearity, dependence of errors, outliers, heteroscedasticity). Significant interactions between covariates and dependent variables were included in the model. We based the covariance structure (Toeplitz Heterogeneous) on the lowest Akaike Information Criterion (AIC), as a lower AIC indicates a better model fit. We included the random intercept as this model presented with a lower AIC. For converters, we calculated deltas of the standardized values for the [i] qualitative fluency measures and [ii] relevant neuropsychological tests between restructured time-point 1 in the six phenoconverters that had data 4 years before phenoconversion, or time-point 2 in the four phenoconverters that only had data 2 years before phenoconversion, and time-point 3 (phenoconversion). We then explored the association between the delta fluency measures and delta neuropsychological tests (corrected for age, sex and education) using partial correlations. Change over time maps were generated by subtracting the GM maps calculated at time-point 3 (phenoconversion) from the maps calculated at time-point 1 or 2 in SPM12. We then explored the relationship between the delta qualitative fluency measures and delta GM maps by means of multiple regression models. Age, sex, TIV, and head coil were entered as covariates. We set the statistical threshold at p < 0.05, adjusted for multiple comparisons with familywise error (FWE) correction. Lastly, to investigate classification abilities of these delta z-scores, we performed binary logistic regression analyses. Assumptions were checked (non-linearity, dependence of errors, outliers, multicollinearity). The models were selected with a forward stepwise method according to the likelihood ratio test and applying the standard p-values for variable inclusion (0.05) and exclusion (0.10). Goodness of fit was evaluated with the HL Χ2 test, with Nagelkerke R2 as measure of effect size. The analyses were adjusted for age, sex, education, and total number of words generated. All models were corrected for multiple comparisons (Bonferroni).

Results

Demographics and clinical data

Demographic and clinical data are shown in Table 1. There were no differences between phenoconverters, non-converters, and controls in age [F(2,117) = 0.212, p = 0.809], sex [X(2) = 1.568, p = 0.457], gene [X(2) = 4.830, p = 0.089] or education level [F(2,117) = 1.290, p = 0.279]. There were no differences between MAPT and GRN phenoconverters in age [F(2,9) = 2.966, p = 0.123], sex [X(2) = 0.524, p = 0.262] or education level [F(2,9) = 0.022, p = 0.945]. We found no differences between phenoconverters, non-converters, and controls regarding baseline MMSE [F(2,117) = 0.229, p = 0.796], FAB [F(2,40) = 2.504, p = 0.095], BDI [F(2,116) = 0.607, p = 0.547] or NPI-Q [F(2,73) = 0.031, p = 0.969]. There were no differences between MAPT and GRN phenoconverters in these measures (all p > 0.05). There were no differences in neuropsychological test scores between group at study entry (all p > 0.05).
Table 1
Demographic and clinical data per subgroup
 
Phenoconverters (n = 10)
Non-converters (n = 53)
Controls (n = 55)
Age at study entry, y
47.9 (9.3)
46.7 (10.6)
48.1 (12.0)
Sex, female (%)
5 (50.0)
33 (62.3)
28 (50.9)
Gene in family
MAPT = 6
GRN = 4
MAPT = 14
GRN = 39
MAPT = 15
GRN = 40
Mutation in family
P301L = 3, G272V = 3, S82fs = 4
P301L = 7, G272V = 1, R406W = 1, L315R = 2, S320F = 2, D252Y = 1, S82fs = 25, Q125X = 10, V411fs = 2, Asp254fs = 1, D254fs = 1
P301L = 7, G272V = 3, R406W = 2, L315R = 1, N296del = 2, S82fs = 23, Q125X = 13, V411fs = 1, Asp254fs = 1, D254fs = 1, Q249X = 1
Clinical diagnosis
bvFTD = 8, nfvPPA = 2
N/A
N/A
Education (level)*
5.7 (0.8)
5.3 (1.2)
5.1 (1.0)
Clinical data at study entry
   
MMSE [0–30]
29.3 (0.8)
29.3 (1.1)
29.2 (1.2)
FAB [0–18]
15.0 (0)
17.2 (0.9)
16.5 (1.5)
BDI [0–63]
5.6 (11.2)
4.4 (5.1)
3.7 (4.4)
NPI-Q [0–36]
0.5 (0.8)
1.4 (18.9)
0.7 (2.6)
BNT [0–60]
54.3 (5.3)
54.0 (4.9)
53.6 (4.3)
SAT verbal [0–30]
27.7 (1.5)
27.8 (1.7)
27.8 (1.3)
TMT-B, seconds
60.4 (22.6)
62.2 (30.0)
67.9 (33.7)
Stroop card III, seconds
94.1 (27.3)
89.5 (23.1)
95.7 (37.9)
Values indicate mean ± SD or n (%)
Abbreviations: MAPT microtubule-associated protein tau, GRN progranulin, C9orf72 chromosome 9 open reading frame 72, bvFTD behavioural variant frontotemporal dementia, nfvPPA non-fluent variant primary progressive aphasia, N/A not applicable, MMSE Mini-Mental State Examination, FAB Frontal Assessment Battery, BDI Beck’s Depression Inventory, NPI-Q neuropsychiatric questionnaire, BNT Boston Naming Test, SAT Semantic Association Test, TMT Trail Making Test
*Dutch educational system categorized into levels from 1 = less than 6 years of primary education to 7 = academic schooling: Duits A KR. Schatten van het premorbide functioneren. In: Hendriks et al. [24]

Interrater reliability

Two independent raters (LCJ, SAAML), blinded to participant’s clinical and genetic status, scored the number of clusters, cluster sizes, and number of switches (see Methods—Qualitative fluency measures, and Appendix 1). The interrater reliability of all three measures was considered ‘good’ (i.e., intraclass correlation coefficients 0.75–0.90) [25]: number of clusters 0.81 [95% CI 0.76–0.85], cluster sizes 0.85 [95% CI 0.81–0.87], and number of switches 0.85 [95% CI 0.81–0.88].

Co-correlation between the qualitative measures

Appendix 2 shows the results of the principal component analysis on the five qualitative measures per time-point. Based on our criteria and visual inspection of the scree plot, we could extract two components. The first component explained between 39.5 and 49.7% of the total variance, and both LF and AoA had high loadings (r > 0.900). The second factor explained between 29.0 and 43.3% of the total variance, and both the number of clusters and the number of switches, and at some time-points also the cluster size, had high loadings (r > 0.59).

Longitudinal qualitative fluency trajectories

The inflection points and longitudinal trajectories of the fluency measures are shown in Table 2. The individual trajectories in phenoconverters are displayed in Fig. 2. Phenoconverters had declining total scores from at least 4 years pre-phenoconversion (p < 0.001), while there was no decline in non-converters or controls (p > 0.05). As can be noted from Fig. 2, the qualitative measures demonstrated more noise in their fluctuation than the total score. Phenoconverters had higher LF from 4 years pre-phenoconversion in comparison to controls (p = 0.016). Also the number of clusters (p < 0.001) and switches (p = 0.004) started to decline at this point. AoA declined from phenoconversion onwards (p = 0.050). No longitudinal change was found for cluster size (p > 0.05). There was no change in qualitative fluency measures in non-converters or controls (p > 0.05). Different inflection points and longitudinal trajectories were found for GRN and MAPT phenoconverters. At least 4 years pre-phenoconversion, GRN phenoconverters started producing fewer words in comparison to controls (p = 0.005). Moreover, they started producing fewer but larger clusters (both p < 0.001), and used fewer switches (p = 0.004). GRN phenoconverters had larger cluster sizes than MAPT phenoconverters (p < 0.001). LF and AoA did not change in GRN phenoconverters compared to controls (p > 0.05). Starting at least 4 years pre-phenoconversion, MAPT phenoconverters produced fewer words than controls (p < 0.001). Moreover, LF started to increase (p = 0.007), while AoA (p = 0.034), the number of clusters (p = 0.009), and cluster size (p = 0.010) declined. The number of switches did not change (p > 0.05).
Table 2
Longitudinal trajectories of the total score and qualitative fluency measures in phenoconverters and non-converters
Time point
Group
n
Total score
LF
AoA
Clusters
Cluster size
Switches
Mean
SD
Mean
SD
Mean
SD
Mean
SD
Mean
SD
Mean
SD
4 years before phenoconversion
Phenoconverters (total)
6
0.29
0.87
− 0.24
0.46
0.03
0.74
0.11
0.91
0.08
1.07
− 0.19
0.87
MAPT Phenoconverters
3
− 0.27
0.42
− 0.19
0.56
− 0.11
0.16
− 0.50
0.51
− 0.52
0.83
− 0.66
0.56
GRN Phenoconverters
3
0.84
0.91
− 0.33
0.42
0.25
1.40
1.03
0.00
0.48
1.16
0.51
0.86
Non-converters
51
− 0.20
0.95
0.11
0.99
− 0.23
0.99
− 0.21
0.88
− 0.02
0.80
− 0.21
0.80
2 years before phenoconversion
Phenoconverters (total)
10
− 0.27
1.08
− 0.04
1.09
− 0.04
0.77
− 0.14
0.65
− 0.21
0.77
− 0.18
0.88
MAPT phenoconverters
6
− 0.59
0.73
0.17
1.32
0.26
0.77
− 0.14
0.75
− 0.05
0.92
− 0.53
0.70
GRN phenoconverters
4
0.22
1.44
− 0.47
0.21
− 0.63
0.29
− 0.14
0.53
− 0.52
0.26
0.53
0.87
Non-converters
42
− 0.12
0.74
− 0.03
1.02
0.06
1.04
0.04
1.03
− 0.26
0.86
0.17
1.11
Phenoconversion
Phenoconverters (total)
10
− 0.86
0.99
− 0.12
1.85
0.31
1.32
− 0.12
0.75
− 0.35
1.29
− 0.77
1.28
MAPT phenoconverters
6
− 1.27
0.43
− 0.50
2.22
0.49
1.61
− 0.12
0.87
− 0.51
1.48
− 1.00
1.39
GRN phenoconverters
4
− 0.25
1.35
0.65
0.33
− 0.05
0.43
− 0.12
0.61
− 0.01
0.97
− 0.31
1.09
Non-converters
38
0.20
0.94
0.08
0.86
− 0.04
0.90
0.07
1.20
0.26
1.17
0.03
1.39
1 year after phenoconversion
Phenoconverters (total)
5
− 1.53
0.76
− 0.13
1.83
− 0.02
1.24
− 0.70
0.74
− 0.97
0.57
− 0.22
1.12
MAPT phenoconverters
3
− 1.86
0.44
− 0.43
2.13
0.09
1.49
− 0.58
0.85
− 1.19
0.46
− 0.43
1.27
GRN phenoconverters
2
− 0.59
0.08
0.85
0.15
− 0.37
0.04
− 1.11
0.06
− 0.33
0.02
0.42
0.02
Non-converters
13
0.55
1.52
− 0.12
1.08
0.00
1.21
0.08
1.03
0.47
1.56
0.07
1.02
2 years after phenoconversion
Phenoconverters (total)
5
− 3.15
0.86
0.94
1.87
− 0.54
3.03
− 2.72
1.03
0.58
2.61
− 2.07
1.19
MAPT phenoconverters
3
− 3.13
1.12
1.77
2.10
− 1.87
3.43
− 2.24
1.13
− 1.31
0.43
− 1.63
1.45
GRN phenoconverters
2
− 3.17
0.23
− 0.30
0.02
1.45
0.03
− 3.44
0.09
− 3.42
0.12
− 2.72
0.05
Non-converters
28
0.26
1.33
− 0.27
1.25
0.53
1.36
0.44
0.99
− 0.16
0.64
0.24
0.82
Values indicate: z-scores (i.e. individual test score minus the mean of the healthy controls, divided by the standard deviation of the healthy controls per time point). Data from healthy controls are omitted from this table as their mean z-score is zero and their standard deviation is one by default. Significant values (p < 0.05) are expressed in bold
Abbreviations: SD standard deviation, LF lexical frequency, AoA age of acquisition, MAPT microtubule-associated protein tau, GRN progranulin

Associations with cognitive decline

Partial correlation coefficients between the fluency measures and relevant neuropsychological tests are shown in Table 3. In phenoconverters, decline on the SAT verbal correlated with an increase in LF (p = 0.031) and a decline in AoA (p = 0.037). Worse performance on TMT-B (p = 0.031) and Stroop-III (p = 0.026) correlated with an increase in cluster size, while worse performance on Stroop-III correlated with a decline in the number of switches (p = 0.031). In GRN phenoconverters, decline on the SAT verbal correlated with a decline in AoA (p = 0.020). Worse performance on Stroop-III correlated with a decline in the number of clusters (p = 0.022), and an increase in cluster size (p = 0.014), while decline on TMT-B correlated with a decline in the number of switches (p = 0.024). In MAPT phenoconverters, decline on the SAT verbal correlated with an increase in LF (p = 0.015) and a decline in AoA (p = 0.014).
Table 3
Partial correlations between decline in fluency measures and relevant cognitive tests
Group
Measure
BNT
SAT verbal
TMT-B
Stroop card III
Phenoconverters total group (n = 10)
LF
− 0.10
− 0.71
0.03
− 0.20
AoA
0.17
0.70
− 0.30
− 0.10
Clusters
0.03
0.44
0.27
0.59
Cluster size
0.36
0.25
− 0.71
− 0.73
Switches
0.16
0.38
0.38
0.72
GRN phenoconverters (n = 4)
LF
0.52
0.96
0.61
0.94
AoA
− 0.72
− 0.99
− 0.79
− 0.83
Clusters
− 0.10
0.60
0.02
0.88
Cluster size
− 0.41
− 0.92
− 0.51
− 0.98
Switches
0.55
− 0.97
0.87
0.93
MAPT phenoconverters (n = 6)
LF
− 0.21
− 0.90
0.44
− 0.51
AoA
0.22
0.90
− 0.12
0.66
Clusters
0.34
0.77
− 0.37
0.32
Cluster size
0.30
0.26
− 0.68
− 0.07
Switches
0.15
0.46
0.65
0.59
Values indicate: partial correlation coefficients (corrected for age, sex and education level). Significant correlations (p < 0.05) are expressed in bold
Abbreviations: BNT Boston Naming Test, SAT Semantic Association Test, TMT Trail Making Test, MAPT microtubule-associated protein tau, GRN progranulin

Associations with GM volume loss

The relationships between the qualitative fluency measures and GM volume loss are displayed in Fig. 3 and Appendix 3. In the total group of phenoconverters, worse performance on all five qualitative fluency measures was associated with GM volume loss in large overlapping areas spanning the frontal (e.g., middle frontal gyrus) and temporal lobes (e.g., middle and superior temporal gyrus), and the anterior insular and cingulate cortices (pFWE-corrected < 0.05). In GRN phenoconverters, an increase in LF and a decline in AoA were associated with GM volume loss of the cerebellum and predominantly temporal areas (e.g., medial temporal lobe, inferior temporal gyrus). A decline in the number of clusters, cluster size, and the number of switches correlated with GM volume loss of the cerebellum, insular cortex, and putamen (pFWE-corrected < 0.05). In MAPT phenoconverters, an increase in LF and a decline in AoA were associated with GM volume loss of the cerebellum and predominantly temporal areas (e.g., anterior temporal pole, inferior temporal gyrus). A decline in the number of clusters, cluster size, and the number of switches correlated with GM volume loss of the cerebellum and predominantly frontal areas (e.g., middle and superior frontal gyrus, frontal pole) (pFWE-corrected < 0.05).

Classification abilities of qualitative fluency measures

Decline in the total score differentiated between phenoconverters and non-converters [X2(1) = 7.669, p = 0.006] and controls [X2(1) = 7.643, p = 0.006]. This was primarily driven by MAPT phenoconverters, as it differentiated well between this group and non-converters [X2(1) = 5.919, p = 0.015] and controls [X2(1) = 5.902, p = 0.015], but not between GRN phenoconverters, non-converters, and controls (p > 0.05). A decline in switches was predictive of phenoconversion in GRN [X2(1) = 5.069, p = 0.024], correctly classifying 90.3% of cases; a decline in cluster size was predictive of phenoconversion in MAPT [X2(1) = 3.894, p = 0.048], correctly classifying 89.3% of cases.

Discussion

This study examined longitudinal changes in qualitative aspects of the semantic fluency task in a large cohort of FTD phenoconverters, presymptomatic mutation carriers, and non-carriers from GRN- and MAPT-FTD families. Phenoconverters showed a decline in the total score from at least 4 years pre-phenoconversion, with individually-varying inflection points and longitudinal trajectories in qualitative fluency measures in GRN and MAPT. At least 4 years pre-phenoconversion, GRN phenoconverters started producing fewer but larger clusters, and switched less between clusters, which was correlated with executive dysfunction. A decline in switching was predictive of phenoconversion. At least 4 years pre-phenoconversion, MAPT phenoconverters demonstrated an increase in LF and a decline in AoA, which was correlated with semantic deficits. A decline in cluster size was predictive of phenoconversion. Increase in LF and decline in AoA were associated with GM volume loss of predominantly temporal areas, while decline in the number of clusters, cluster size, and switches correlated with GM volume loss of predominantly frontal areas.
The semantic fluency total score is strongly intertwined with the qualitative aspects of the task. For accurate and timely word retrieval, both AoA and LF [26], and clustering and switching components [27] are required. Coinciding with the results of our principal component analysis, in which we found a AoA-LF component and a clusters-switches component, previous studies found strong correlations between AoA and LF, and between the number of clusters and the number of switches. With respect to the relation between AoA and LF, correlations have found to be high in natural languages, as early-acquired words tend to occur more frequently than late-required words [28]. The number of switches and the number of clusters are correlated, as by identifying the number of clusters, one can generate the number of switches (corresponds to the number of clusters minus one) [27].
Irrespective of the underlying FTD mutation, we showed a decline in the total score in mutation carriers from at least 4 years prior to phenoconversion. Decline in semantic fluency was found to be an early cognitive marker in other neurodegenerative diseases. For instance, in preclinical AD and Huntington’s disease, as early as 12 years before the onset of dementia, decline in a measure of semantic memory was found [29, 30]. In another study, it was amongst the most statistically sensitive cognitive measures of symptomatic conversion [31]. Studies into semantic fluency decline in presymptomatic FTD have shown somewhat contrasting results. One study demonstrated decline in semantic fluency in MAPT mutation carriers from 6 years before estimated symptom onset [7], whereas another only found decline at estimated symptom onset [6]. It should be noted that both studies used estimated years to symptom onset as a proxy for actual onset, which can be less reliable in familial FTD [6]. Utilizing a similar research design as our current study, decline of semantic fluency from 4 years before symptom onset in MAPT converters, and decline of semantic fluency was found to be the best predictor for having an MAPT mutation [8]. Although semantic fluency did not decline in GRN converters, decline on phonemic fluency was found to be predictive of an GRN mutation, confirming the value of fluency tasks in presymptomatic FTD as they can distinguish the underlying genotype [8].
Starting at least 4 years pre-phenoconversion, GRN mutation carriers produced fewer but larger clusters, and had fewer switches, than MAPT phenoconverters and controls. A likely explanation for the decline in their total score is that GRN phenoconverters deteriorate in cognitive flexibility [32], and thereby lose the ability to switch between semantic clusters in order to generate more words. Indeed, in our study the decline in the number of clusters and switches, and the increase in cluster size, correlated with decline in executive function. Executive dysfunction is known to be a distinctive cognitive feature in GRN mutations, demonstrating deficits in symptomatic mutation carriers [33], extending to the presymptomatic stage [7, 8]. When converting to the symptomatic stage, GRN mutation carriers also show the most decline in executive function [34].
Starting at least 4 years pre-phenoconversion, MAPT mutation carriers produced words with a higher LF and a lower AoA, and had fewer clusters and smaller clusters than GRN phenoconverters and controls. These findings point towards deterioration of the semantic system as an explanation as to why qualitative fluency measures change in MAPT. First, semantic decline is most likely to affect words with a lower LF and a higher AoA first, as the categorical organization of the system retrieves the ‘typical’ exemplars faster and more accurately, and they are better represented and more interconnected to other concepts than those that enter the semantic system later in life [35]. The reliance of both processes on semantic processing is further supported by their correlation with the verbal SAT which assesses verbal semantic deficits [36]. Clustering relies on lexical retrieval, vocabulary size and lexical access, and thus is mainly supported by the integrity of the semantic system [13].
We demonstrated that—irrespective of the underlying mutation—decline in the number of clusters, cluster size, and switches correlated with GM volume loss of predominantly frontal areas, while worse LF and AoA performance was associated with GM volume loss of predominantly temporal areas. These neuroanatomical correlates are in line with the predominant frontal involvement in GRN mutation carriers [6, 34], and link the degradation of the fronto-insula network to less cognitive flexibility—and as a consequence early clustering-switching impairment—as the most likely underpinning of declining fluency performance in conversion to GRN-associated FTD. The finding that LF and AoA rely on temporal lobe functioning could explain why these qualitative features are changing early in MAPT mutation carriers, as temporal volume loss is considered the neuroimaging hallmark of MAPT [37, 38], being present up to several decades before symptom onset [39]. Although PPA is not a frequent clinical phenotype, semantic impairments are well-described in MAPT-related FTD [40]. Our cohort includes three P301L and three G272V phenoconverters, which is too small to investigate differences between the two tau mutations. Nevertheless, with larger sample sizes it would be interesting to explore if there is clinical heterogeneity across the MAPT mutations [41], as the P301L mutation often presents with a language phenotype with semantic deficits [42]. Impairments in semantic fluency are found to be common as the result of cerebellar pathology, as this subcortical region plays a crucial role in motor performance and executive processes necessary for organizing and monitoring word output [43].
The key strength of our study is our longitudinal design, spanning up to 6 years of follow-up in a large single-centre sample of participants from GRN and MAPT FTD-families. This design allowed the investigation of mutation carriers as they were converting to the symptomatic stage, which provides us more accurate information about the underlying disease process than previous studies that used estimated years to onset as a proxy [40]. We chose multilevel linear modelling to handle potential missing data and unbalanced time-points that were the result of our ongoing prospective study. The small sample of phenoconverters, in combination with the large fluctuations in the data of the qualitative measures, are the largest drawback of the study, which has hampered our statistical power and interpretation of results. As the multilevel model assumes a linear relationship between genetic status and fluency performance it is possible that we have missed non-linear effects. Ideally, the semantic fluency test should not have been used in determining phenoconversion, however in our multidisciplinary approach we have used all available clinical information—e.g., MR brain imaging, anamnestic and heteroanamnestic information, questionnaires—so that symptom onset did not solely depend on the neuropsychological assessment. Although theoretically a cluster can consist of a single word, one cannot measure interword intervals for fewer than two words, so that a single-word “cluster” cannot be corroborated by the measurement of interword intervals. Following Ledoux et al. [11], we therefore defined clusters not as single words, but only as multiword strings (i.e. two or more consecutive words) whose relationship is defined by one of the scoring rules, but realize this could have penalized patients with a low total output. Lastly, the analyses on the presymptomatic mutation carriers were performed using the original baseline and follow-up visits, regardless of years from potential phenoconversion, therefore they might have lost some sensitivity to detect decline. Future directions include replication of our findings in larger multicentre cohorts, including C9orf72 mutation carriers. Moreover, using qualitative measures in discriminative event-based models could help us understand the dynamics of disease progression and how other biomarkers (e.g., NfL) fit into this [44]. Lastly, future studies could look into the effect of using time-bins next to the usual 60-s output, as most people start with readily available animals and produce less familiar exemplars as the task develops (which affects the qualitative measures), and was found to be particularly sensitive to mutation status in presymptomatic APOE-ε4 carriers at-risk of developing AD [14].

Conclusion

Our pilot study shows that qualitative aspects of semantic fluency change in presymptomatic FTD, and shows different profiles and inflection points depending on the mutation involved. This could provide important insight into the mechanisms as to why the “traditional” total score is declining. Its brief and easy-to-apply nature makes the total score of the semantic fluency test a likely candidate cognitive biomarker for upcoming clinical trials for FTD, but more research with a larger sample of phenoconverters is needed to replicate our findings, and to explore the additional value of qualitative measures in identifying and tracking mutation carriers as they convert to the symptomatic stage.

Acknowledgements

The authors thank all the participants and their families for taking part in the FTD-RisC study.

Declarations

Conflicts of interest

The authors have no competing interests to declare that are relevant to the content of this article.

Ethical approval

The investigators and participants were blinded for the genetic status of the at-risk participants, except for those that underwent predictive testing (27.8%). All participants provided written informed consent. The Erasmus MC ethics committee gave approval for the study (MEC 2009-409). This study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Appendix 1: Scoring guidelines for qualitative aspects of semantic fluency

General scoring rules

When more than three words were missing from the fluency output (e.g., word was illegible or there was a tick instead of a word written), only the total number of words generated was used for further analyses (i.e., no qualitative aspects were calculated). For the total number of words generated, only correct words were used, thus no perseverative, pseudo or rule-break errors were included. Clusters were allowed to (partially) overlap. ‘Embedded’ clusters (i.e., a cluster within a cluster) were not taken into account. In determining the total cluster size, words that belonged to more than one cluster were counted twice (e.g., pig belongs to the cluster “farm animals” as well as the cluster “porcine”). In determining the number of switches, overlapping clusters were also counted as a switch. The beginning and end of the output were not taken into account as a switch.

Ad hoc scoring rules for LF and AoA

For LF and AoA the original fluency output was followed if possible. If a word was not found in the databases for either LF [25] or AoA [26] the following ad hoc scoring rules were followed: 1. finding the singular of this word in the database (e.g., pig instead of pigs); 2. finding the word in the database with the adjective removed (e.g., bear instead of polar bear). When the word was still not available, a different value was used: for LF it was assumed that the missing word occurred only once in the language corpus. With this assumed frequency a Zipf-value of ‘’zero frequency’’ was calculated. For AoA, an imputed value was used when the word was not available in the database. The imputed value was based on the highest age of acquisition score (15.1) within this study.

Cluster scoring rules*

Words that belong to the same subcategory
E.g., pets; dog, cat, rabbit
Words that have a strong association in the real world
E.g., cat, mouse
Words that share the same first letter
E.g., fish, ferret
Words that share the same first sound
E.g., cat, kangaroo
Words that share the same word
E.g., horse, seahorse
Words that rhyme
E.g. cat, rat
Based on Ledoux et al. [11] and Troyer et al. [24]

Appendix 2: Principal component analysis on the five qualitative fluency measures

Items
Component coefficients
Communalities
1
2
4 years before phenoconversion
   
 LF
− 0.958
0.025
0.915
 AoA
0.950
0.033
0.904
 Clusters
0.061
0.888
0.792
 Cluster size
0.535
− 0.593
0.637
 Switching
− 0.014
0.907
0.824
 Eigenvalues
2.314
1.758
 
 Variance, %
46.280
35.167
 
2 years before phenoconversion
 LF
0.975
0.025
0.951
 AoA
0.970
− 0.024
0.941
 Clusters
0.172
0.837
0.731
 Cluster size
0.235
− 0.807
0.706
 Switching
0.039
0.902
0.815
 Eigenvalues
1.977
2.167
 
 Variance, %
39.542
43.332
 
Phenoconversion
 LF
− 0.942
0.034
0.888
 AoA
0.948
− 0.137
0.918
 Clusters
0.424
0.093
0.188
 Cluster size
0.228
− 0.839
0.756
 Switching
0.249
0.855
0.793
 Eigenvalues
2.096
1.448
 
 Variance, %
41.922
28.965
 
1 year after phenoconversion
 LF
− 0.959
− 0.015
0.920
 AoA
0.950
0.103
0.913
 Clusters
0.047
− 0.350
0.629
 Cluster size
0.711
0.919
0.847
 Switching
− 0.124
0.924
0.869
 Eigenvalues
2.420
1.758
 
 Variance, %
48.396
35.156
 
2 years after phenoconversion
   
 LF
− 0.929
− 0.220
0.912
 AoA
0.938
0.168
0.907
 Clusters
0.197
0.903
0.853
 Cluster size
0.606
− 0.624
0.756
 Switching
0.196
0.904
0.855
 Eigenvalues
2.484
1.800
 
 Variance, %
49.679
35.995
 
Abbreviations: LF lexical frequency, AoA Age of Acquisition

Appendix 3: Neuroimaging correlates of the qualitative fluency measures

Group
Measure
Cluster
T
P FWE-corrected
MNI coordinates
Region
x
y
z
Total group of phenoconverters
LF
71,256
73.01
< 0.001
33
20
− 4
Anterior insula R
851
77.34
< 0.001
− 33
16
52
Middle frontal gyrus L
639
49.57
< 0.001
− 20
42
34
Superior frontal gyrus L
476
81.60
< 0.001
− 33
16
54
Middle frontal gyrus L
438
32.65
< 0.001
56
− 45
2
Middle temporal gyrus R
426
26.97
< 0.001
60
− 26
0
Superior temporal gyrus R
124
38.36
< 0.001
− 24
2
− 48
Temporal pole L
117
27.64
0.002
− 22
− 3
− 46
Inferior temporal gyrus L
AoA
98,828
88.54
< 0.001
− 33
16
56
Middle frontal gyrus L
1038
37.85
< 0.001
− 32
42
30
Middle frontal gyrus L
442
32.71
< 0.001
57
− 42
4
Middle temporal gyrus R
425
28.39
< 0.001
60
− 26
0
Superior temporal gyrus R
348
24.14
< 0.001
54
− 60
− 8
Inferior temporal gyrus R
171
31.55
< 0.001
− 32
56
12
Middle frontal gyrus L
Clusters
10,400
70.87
< 0.001
− 33
− 6
9
Anterior insula L
774
66.01
< 0.001
63
− 38
30
Supramarginal gyrus R
401
58.95
< 0.001
− 34
18
57
Middle frontal gyrus L
341
24.59
0.005
54
− 60
− 8
Inferior temporal gyrus R
254
40.05
< 0.001
− 32
42
30
Middle frontal gyrus L
191
35.09
< 0.001
− 51
− 48
18
Superior temporal gyrus L
135
24.82
0.005
− 4
32
48
Superior frontal gyrus L
Cluster size
80,154
89.77
< 0.001
− 3
9
38
Middle cingulate gyrus L
1513
37.39
< 0.002
56
− 45
3
Middle temporal gyrus
714
44.30
< 0.001
63
− 38
30
Supramarginal gyrus R
390
24.13
< 0.001
57
− 63
− 2
Inferior temporal gyrus R
265
39.38
0.002
− 32
42
30
Middle frontal gyrus L
232
27.25
0.006
− 21
39
40
Superior frontal gyrus L
Switches
70,083
67.98
< 0.001
33
18
− 4
Anterior insula R
1420
31.22
0.001
8
16
57
Supplementary motor cortex R
766
44.18
< 0.001
63
− 38
28
Supramarginal gyrus R
502
33.31
< 0.001
57
− 42
4
Middle temporal gyrus R
487
58.10
< 0.001
− 34
18
57
Middle frontal gyrus L
435
28.07
0.002
46
− 52
8
Inferior temporal gyrus R
373
26.80
0.003
62
− 18
− 3
Superior temporal gyrus R
286
50.52
< 0.001
44
− 51
48
Angular gyrus R
277
29.04
0.001
− 50
− 63
− 32
Cerebellum L
276
60.77
< 0.001
− 33
42
32
Middle frontal gyrus L
179
28.99
0.001
− 22
39
42
Superior frontal gyrus L
GRN phenoconverters
LF
122
114.52
0.002
3
− 52
− 12
Cerebellum R
72
99.72
0.002
− 30
0
− 18
Medial temporal lobe L
60
114.68
0.002
27
− 44
− 24
Cerebellum R
32
92.53
0.002
40
− 57
− 42
Cerebellum R
28
111.21
0.002
− 20
− 46
− 21
Cerebellum L
25
93.84
0.002
− 34
10
− 10
Anterior insula L
18
95.61
0.002
− 39
− 78
− 33
Cerebellum L
AoA
142
113.75
0.002
0
− 52
− 14
Cerebellum L
85
116.16
0.002
24
− 44
− 24
Cerebellum R
55
96.63
0.002
− 38
− 8
6
Anterior insula L
38
91.25
0.002
− 28
0
− 16
Medial temporal lobe L
23
106.62
0.002
− 20
− 46
− 22
Cerebellum L
15
93.90
0.002
− 57
− 46
− 21
Inferior temporal gyrus L
Clusters
328
133.16
0.002
18
− 66
− 21
Cerebellum R
141
127.04
0.002
− 38
− 9
− 4
Posterior insula L
119
122.36
0.002
− 2
− 52
− 10
Cerebellum L
106
128.52
0.002
− 20
− 52
− 20
Cerebellum L
64
109.98
0.002
− 20
8
− 12
Putamen L
20
106.12
0.002
21
− 38
− 26
Cerebellum R
17
113.55
0.002
33
20
− 4
Anterior insula R
Cluster size
150
119.60
0.002
0
− 52
− 14
Cerebellum L
89
111.33
0.002
− 36
− 9
− 4
Posterior insula L
72
117.38
0.002
24
− 44
− 22
Cerebellum R
43
102.41
0.002
− 20
8
− 12
Putamen L
11
98.60
0.002
33
21
− 4
Anterior insula R
Switches
114
112.68
0.002
− 3
− 52
− 14
Cerebellum L
104
113.17
0.002
− 22
− 50
− 24
Cerebellum L
69
121.55
0.002
− 22
9
− 6
Putamen L
57
115.68
0.002
− 36
− 4
− 6
Posterior insula L
35
103.79
0.002
5
− 50
− 16
Cerebellum R
33
104.91
0.002
21
− 39
− 24
Cerebellum R
27
102.79
0.002
− 24
− 74
− 21
Cerebellum L
MAPT phenoconverters
LF
25,864
143.78
< 0.001
22
− 84
− 27
Cerebellum R
117
18.41
< 0.001
33
22
− 40
Inferior temporal gyrus R
58
23.94
< 0.001
40
− 4
− 51
Temporal pole R
38
29.20
< 0.001
− 32
20
− 30
Temporal pole L
35
16.10
< 0.001
− 39
21
− 38
Temporal pole L
28
16.07
0.002
51
21
− 21
Temporal pole R
AoA
26,431
147.06
< 0.001
22
− 84
− 27
Cerebellum R
119
18.43
< 0.001
33
22
− 40
Temporal pole R
47
23.08
< 0.001
39
− 6
− 51
Inferior temporal gyrus R
27
15.77
< 0.001
51
21
− 20
Temporal pole R
Clusters
22,010
144.32
< 0.001
22
− 84
− 28
Cerebellum R
1669
68.58
< 0.001
− 32
44
30
Middle frontal gyrus L
342
57.46
< 0.001
45
24
42
Middle frontal gyrus R
310
24.65
< 0.001
4
58
32
Superior frontal gyrus R
224
33.39
< 0.001
− 4
60
18
Superior frontal gyrus L
216
56.60
< 0.001
38
46
28
Middle frontal gyrus R
201
25.60
< 0.001
51
42
14
Middle frontal gyrus R
134
24.15
< 0.001
36
28
54
Middle frontal gyrus R
Cluster size
21,760
146.75
< 0.001
34
− 42
− 30
Cerebellum R
1509
71.70
< 0.001
− 32
44
28
Middle frontal gyrus L
382
43.23
< 0.001
45
24
44
Middle frontal gyrus R
238
28.06
< 0.001
− 4
60
20
Superior frontal gyrus L
236
21.36
< 0.001
20
63
− 16
Frontal pole R
228
24.25
< 0.001
4
58
32
Superior frontal gyrus R
212
43.14
< 0.001
− 21
44
42
Superior frontal gyrus L
194
23.61
< 0.001
50
40
14
Middle frontal gyrus R
185
25.34
< 0.001
− 46
52
− 2
Middle frontal gyrus L
167
44.46
< 0.001
38
48
28
Middle frontal gyrus R
103
20.98
< 0.001
36
28
52
Middle frontal gyrus R
Switches
22,641
152.76
< 0.001
24
− 82
− 28
Cerebellum R
297
37.51
< 0.001
44
26
42
Middle frontal gyrus R
173
38.47
< 0.001
26
51
36
Superior frontal gyrus R
149
25.54
< 0.001
4
58
32
Superior frontal gyrus R
144
20.55
< 0.001
34
21
− 39
Temporal pole R
132
24.69
< 0.001
− 21
42
45
Superior frontal gyrus L
Abbreviations: LF lexical frequency, AoA Age of Acquisition, GRN progranulin, MAPT microtubule-associated protein tau, L left, R right
Fußnoten
1
We used the scoring rules of Ledoux et al. [11] here, in which the scoring of clusters is restricted to strings of two or more successive words. Although theoretically a cluster can consist of only a single word, one cannot measure interword intervals for fewer than two words, thus a single-word cluster cannot be corroborated by the measurement of interword intervals. Reference: Ledoux et al. [11].
 
Literatur
12.
Zurück zum Zitat Vonk JMJ, Jonkers R, Hubbard HI, Gorno-Tempini ML, Brickman AM, Obler LK (2019) Semantic and lexical features of words dissimilarly affected by non-fluent, logopenic, and semantic primary progressive aphasia. J Int Neuropsychol Soc 25(10):1011–1022CrossRefPubMedPubMedCentral Vonk JMJ, Jonkers R, Hubbard HI, Gorno-Tempini ML, Brickman AM, Obler LK (2019) Semantic and lexical features of words dissimilarly affected by non-fluent, logopenic, and semantic primary progressive aphasia. J Int Neuropsychol Soc 25(10):1011–1022CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Thurstone LL (1938) Primary mental abilities. University of Chicago Press, Chicago Thurstone LL (1938) Primary mental abilities. University of Chicago Press, Chicago
23.
Zurück zum Zitat DeVellis RF (2003) Scale development: theory and applications, vol 26, 2nd edn. Sage Publications, Thousand Oaks DeVellis RF (2003) Scale development: theory and applications, vol 26, 2nd edn. Sage Publications, Thousand Oaks
24.
Zurück zum Zitat Hendriks MKR, Gorissen M, Schmand BDA (eds) (2014) Neuropsychologische diagnostiek. Boom, pp 176–178 Hendriks MKR, Gorissen M, Schmand BDA (eds) (2014) Neuropsychologische diagnostiek. Boom, pp 176–178
26.
Zurück zum Zitat Meschyan G, Hernandez A (2002) Age of acquisition and word frequency: determinants of object-naming speed and accuracy. Mem Cognit 30:262–269CrossRefPubMed Meschyan G, Hernandez A (2002) Age of acquisition and word frequency: determinants of object-naming speed and accuracy. Mem Cognit 30:262–269CrossRefPubMed
27.
Zurück zum Zitat Carlesso K, Eduara P, Fernandes G, Diehl M, Rodrigues C, Rochele P, Fonseca P, Fernanda Altmann R (2022) Clustering and switching in verbal fluency: a comparison between control and individuals with brain damage. CoDAS 34(2):e20200365CrossRef Carlesso K, Eduara P, Fernandes G, Diehl M, Rodrigues C, Rochele P, Fonseca P, Fernanda Altmann R (2022) Clustering and switching in verbal fluency: a comparison between control and individuals with brain damage. CoDAS 34(2):e20200365CrossRef
28.
Zurück zum Zitat Yum YN, Law S-P (2019) Interactions of age of acquisition and lexical frequency effects with phonological regularity: an ERP study. Psychophysiology 56:e13433CrossRefPubMed Yum YN, Law S-P (2019) Interactions of age of acquisition and lexical frequency effects with phonological regularity: an ERP study. Psychophysiology 56:e13433CrossRefPubMed
30.
Zurück zum Zitat Larsson MU, Almkvist O, Luszcz MA, Robins Wahlin TB (2008) Phonemic fluency deficits in asymptomatic gene carriers for Huntington’s disease. Neuropsychology 22(5):596–605CrossRefPubMed Larsson MU, Almkvist O, Luszcz MA, Robins Wahlin TB (2008) Phonemic fluency deficits in asymptomatic gene carriers for Huntington’s disease. Neuropsychology 22(5):596–605CrossRefPubMed
34.
Zurück zum Zitat Jiskoot LC, Panman JL, Meeter LH et al (2019) Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia. Brain 142(1):193–208CrossRefPubMed Jiskoot LC, Panman JL, Meeter LH et al (2019) Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia. Brain 142(1):193–208CrossRefPubMed
36.
Zurück zum Zitat Visch-Brink ESD, Denes G (2005) Semantische associatie test. Swets & Zeitlinger Visch-Brink ESD, Denes G (2005) Semantische associatie test. Swets & Zeitlinger
37.
Zurück zum Zitat Rohrer JD (2012) Structural brain imaging in frontotemporal dementia. Review. Biochimica Et Biophysica Acta-Mol Basis Dis 1822(3):325–332CrossRef Rohrer JD (2012) Structural brain imaging in frontotemporal dementia. Review. Biochimica Et Biophysica Acta-Mol Basis Dis 1822(3):325–332CrossRef
38.
Zurück zum Zitat Young AL, Marinescu RV, Oxtoby NP et al (2018) Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun 4273:1–16 Young AL, Marinescu RV, Oxtoby NP et al (2018) Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun 4273:1–16
42.
Zurück zum Zitat Borrego-Écija S, Morgado J, Palencia-Madrid L et al (2017) Frontotemporal dementia caused by the P301L mutation in the MAPT gene: clinicopathological features of 13 cases from the same geographical origin in Barcelona, Spain. Dementia Geriatr Cogn Disord 44(3–4):213–221. https://doi.org/10.1159/000480077CrossRef Borrego-Écija S, Morgado J, Palencia-Madrid L et al (2017) Frontotemporal dementia caused by the P301L mutation in the MAPT gene: clinicopathological features of 13 cases from the same geographical origin in Barcelona, Spain. Dementia Geriatr Cogn Disord 44(3–4):213–221. https://​doi.​org/​10.​1159/​000480077CrossRef
43.
Zurück zum Zitat Arasanz CP, Staines WR, Roy EA, Schweizer TA (2012) The cerebellum and its role in word generation: a cTBS study. Cortex 48:718–724CrossRefPubMed Arasanz CP, Staines WR, Roy EA, Schweizer TA (2012) The cerebellum and its role in word generation: a cTBS study. Cortex 48:718–724CrossRefPubMed
Metadaten
Titel
Longitudinal changes in qualitative aspects of semantic fluency in presymptomatic and prodromal genetic frontotemporal dementia
verfasst von
Lize C. Jiskoot
Esther van den Berg
Sascha A. A. M. Laenen
Jackie M. Poos
Lucia A. A. Giannini
Djaina D. Satoer
Judy van Hemmen
Yolande A. L. Pijnenburg
Jet M. J. Vonk
Harro Seelaar
Publikationsdatum
18.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2023
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-023-11845-5

Weitere Artikel der Ausgabe 11/2023

Journal of Neurology 11/2023 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.